Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Deficit) (Details Narrative)

v3.26.1
Stockholders’ Equity (Deficit) (Details Narrative) - USD ($)
 3 Months Ended
May 14, 2025
Feb. 26, 2025
Mar. 31, 2026
Dec. 31, 2025
Nov. 20, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock, shares authorized     250,000,000 250,000,000  
Common stock, par value     $ 0.001 $ 0.001 $ 0.001
Preferred stock, shares authorized     15,000,000 15,000,000  
Preferred stock, par value     $ 0.01 $ 0.01  
Placement agents   21,145      
Proceeds from private placement   $ 686,000      
Other offering expenses   $ 70,000      
Issuance of warrants, exercisable   302,069      
Exercise price   $ 2.8375      
Warrant term   5 years      
Equity issuance cost     $ 1,100,000    
Conversion price     $ 0.454    
Fair Value Adjustment     $ 433,000    
Dividend amount        
Series C Preferred Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Preferred stock, par value     $ 0.01    
Preferred stock, shares outstanding     96,230 96,230  
Series L Preferred Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Preferred stock, shares outstanding     4,343 3,642  
Conversion price     $ 0.454    
Dividend amount     $ 103,000    
Shares issued for dividends     $ 267,794    
Series L Preferred Stock [Member] | May 2025 Private Placement [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Shares issued     4,611    
Aggregate Stated Value     $ 4,611,111    
Proceeds from issuance of preferred stock     $ 4,150,000    
Conversion price     $ 0.454    
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share price   $ 4.35      
Dividend amount        
Inducement Warrants [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Placement agents   604,138      
Exercise price   $ 2.27      
Series A Inducement Warrants [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Placement agents   302,069      
Exercise price   $ 2.02      
Warrant term   5 years      
Series B Inducement Warrants [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Placement agents   302,069      
Exercise price   $ 2.02      
Warrant term   18 months      
Purchase Agreement [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants to purcahse $ 20,000,000        
Weighted average volume price of common stock percentage 93.00%        
Placement agents 300,000